Mitochondrial DNA: A Key Player in Cell Death and Inflammation

Overview of factors inducing mtDNA release

Cytosolic DNA is recognized by the innate immune system as a potential threat. During apoptotic cell death, mitochondrial DNA (mtDNA) release activates the DNA sensor cyclic GMP–AMP synthase (cGAS) to promote a pro-inflammatory type I interferon response. This inflammation can engage anti-tumor immunity, offering a potential avenue for cancer therapy.

Stephen W.G. Tait explained that various studies have described mtDNA leakage independent of cell death, triggered by pathogenic infections, changes in mtDNA packaging, mtDNA stress, or reduced mitochondrial clearance. While the interferon response in these scenarios can be beneficial, it may also contribute to disease phenotypes. Understanding the cues and factors inducing mtDNA leakage into the cytosol during cell death and beyond is crucial to purposely promote (e.g., in cancer, infections) or hinder (e.g., mtDNA-associated disease phenotypes) mtDNA release pharmacologically.

During apoptosis, mtDNA is released upon mitochondrial outer membrane permeabilization (MOMP) in caspase-deficient conditions. The cytosolic mtDNA activates the DNA sensor cGAS, inducing an NFκB and type I interferon response, thereby promoting inflammation. Beyond apoptosis, other cues such as mitochondrial stress, mtDNA stress, and pathogenic infections induce mtDNA release through distinct mechanisms, causing inflammation via activation of DNA sensors (cGAS) and receptors (NLRP3, AIM2, or TLR9).

To date, mtDNA release has been observed in a variety of systems and circumstances, resulting in inflammatory gene expression. However, the mechanistic insight into how mtDNA reaches the cytosol and how its recognition is regulated remains ambiguous and requires further research. Moreover, understanding the impact of mtDNA-driven inflammation in health and disease is vital for pharmacological intervention and necessitates in-depth knowledge of the pathway.

Dr. Stephen Tait will present his latest findings on mitochondria and inflammation at the Targeting Mitochondria 2024 conference on October 29-31 in Berlin.

Article DOI.

Exploring Age-Related Changes in Mitochondrial Structure and Function

Mitochondria, essential organelles with dual membranes, are the energy powerhouses of cells. Their inner membrane folds, known as cristae, are crucial for enhancing the organelle’s energy production capabilities.

While oxidative stress is a natural byproduct of mitochondrial activity, excessive stress can lead to dysfunction, aging, and diseases. The structural and functional changes in mitochondria vary significantly across different tissues.

The study, published in Advanced Biology, revealed that while overall mitochondrial size increases with age, the surface area, volume, and complexity of cristae decrease, which affects thermogenic capacity and overall metabolic health.

Changes in Cristae and Mitochondrial Structure

The study discovered that while the overall size of mitochondria increases with age, the surface area, volume, and complexity of cristae diminish. This structural change impacts the mitochondria's efficiency and functionality in energy production.

Influence on Thermogenic Capacity

Mitochondrial shape was found to significantly affect the thermogenic capability of brown adipose tissue (BAT). Round or spherical mitochondria were associated with higher thermogenic function, whereas elongated mitochondria showed reduced thermogenic capacity and were more common in older subjects.

Future Perspectives

- Exploration of Sex-Dependent Differences: The research team plans to investigate whether there are differences in mitochondrial structure and function that are dependent on sex as individuals age.
- Broader Implications for Aging and Metabolic Health: By studying mitochondrial structure across different tissues and species, the team hopes to gain a deeper understanding of aging mechanisms and identify potential therapeutic targets for treating age-related ailments and mitochondrial dysfunctions.

Stay tuned for Targeting Mitochondria 2024 this October for more updates mitochondria reseacrh and aging.

Read the full paper.

Mitochondrial Extracellular Vesicles: Promising Therapeutic Strategy for Neurological Diseases

A recent paper by Dr. Stefano Pluchino, University of Cambridge and invited speaker at Targeting Mitochondria 2024, in collaboration with colleagues from the University of Duisburg-Essen, highlights the transformative potential of extracellular vesicles (EVs) in treating neurological diseases, providing a comprehensive overview of their versatile mechanisms and therapeutic promise.

Extracellular vesicles (EVs) are naturally occurring membrane particles that play a crucial role in cellular communication. Unlike traditional pharmacological treatments that target specific signaling pathways, EVs offer a multifaceted approach by modulating complex disease processes through various effectors. This unique capability positions EVs as powerful agents in promoting brain tissue recovery.

Cartoon summarizing major modes of actions of extracellular vesicles that are therapeutically administered via different routes in diverse disease conditions including stroke, multiple sclerosis or neurodegenerative diseases. The different modes of action, which comprise immune modulation, nuclear signalling, metabolic reprogramming and promotion of neuronal plasticity, synergistically contribute to the recovery-promoting effects of extracellular vesicles (EVs). For therapeutic purposes, unmodified EVs are currently evaluated, as well as EVs that have genetically been modified enabling prolonged EV circulation in the blood, enhanced brain uptake or enhanced signalling action, respectively.

The study reveals that EVs derived from different cellular sources can induce significant therapeutic responses in experimental models of neurological diseases. When administered in vivo, EV-based treatments have shown remarkable effects on immune responses, cell metabolism, and neuronal plasticity. This multimodal influence on neuroimmune networks enables EVs to modulate disease processes synergistically and context-dependently, leading to profound neurological recovery.

Dr. Pluchino and his team provide a detailed exploration of how EVs identify cellular targets and transmit signals to recipient cells. They highlight the relevance of these mechanisms in key neurological conditions such as stroke, multiple sclerosis, and neurodegenerative diseases. The review discusses critical pathways that warrant further investigation in specific disease contexts, showcasing the potential of EVs to revolutionize treatment approaches.

The paper also addresses important considerations regarding EV biodistribution and the genetic engineering strategies designed to enhance brain uptake and signaling. These advances aim to maximize the therapeutic efficacy of EVs, ensuring targeted delivery and robust clinical outcomes.

The researchers also outline the future clinical applications of EVs and propose essential information required for the successful translation of EV-based therapies into clinical trials. This forward-looking perspective highlightses the potential of EVs as next-generation therapeutics for brain diseases, emphasizing the need for rigorous scientific discussion and clinical validation.

Read the full paper.

Dr. Pluchino will be joining Targeting Mitochondria 2024 this October to develop this topic with a talk entitled "Mitochondrial Extracellular Vesicles: Orchestrating Brain Plasticity and Recovery".

Learn more about Dr. Pluchino's talk.

HDL-C and Ferritin: Key Metabolic Indicators of Long COVID-19 Severity Revealed, Opening New Avenues for Treatment Strategies

Study reveals HDL-C and ferritin as crucial markers for long COVID-19 severity, leading to novel treatment strategies. 

Long COVID-19, or post-acute sequelae of SARS-CoV-2 infection (PASC), is a global health phenomenon characterized by persistent symptoms following the acute phase of COVID-19. Affecting millions worldwide, it leads to sustained healthcare needs and impacts workforce participation due to symptoms such as fatigue and cognitive impairments. The condition highlights the necessity for ongoing research, healthcare system adjustments, and the formulation of targeted treatments to address its prolonged effects on individuals and economies.

A recently published study in Clinics Journal (Elsevier) has shed light on significant metabolic changes in non-vaccinated individuals with Long COVID-19, offering key insights into disease severity. This study was led by Marvin Edeas, MD, PhD, Université de Paris, Institut Cochin, INSERM 1016, France, and a team of international researchers led by Jumana Saleh, PhD, Sultan Qaboos University Hospital, Oman.

Published under the title “Reduced HDL-cholesterol in Long COVID-19: A Key Metabolic Risk Factor Tied to Disease Severity”, the study examined 88 patients across varying degrees of initial disease severity (mild, moderate, and severe) compared to a control group comprising 29 healthy individuals.

Findings from the controlled study revealed major metabolic shifts, particularly a substantial reduction in HDL-cholesterol (HDL-C) levels, coupled with a twofold increase in ferritin levels and insulin resistance among severe Long COVID-19 cases, compared to milder cases and the control group. These metabolic markers emerged as leading predictors of disease severity, offering novel understandings of Long COVID-19 management and treatment.

Marvin Edeas explained, “Our research has, for the first time, established a direct correlation between HDL-C and ferritin levels and the severity of Long COVID-19. The decline in HDL-C levels and the rise in ferritin levels observed in patients, influenced by the severity of the initial infection, could potentially play a role in the persistence and progression of Long COVID-19 symptoms”. This study is critical in understanding Long COVID-19 and its long-term impacts on metabolic health.

The research findings suggest that HDL-C and ferritin levels could serve as crucial markers and therapeutic targets, opening new avenues for treatment strategies aimed at mitigating the long-term effects of the disease. By considering these metabolic markers, we can shape preventive strategies and significantly mitigate the long-term impacts of COVID-19 on patients’ health.

The Function of HDL-C in Immune Response Modulation

The observed correlation between diminished levels of HDL-cholesterol (HDL-C), the severity of COVID-19, and its prolonged course might be explained by HDL-C's function as a modulator of the immune response. This includes its roles as an anti-inflammatory, antioxidant, and antiatherogenic agent, particularly vital during the heightened inflammatory response triggered by the virus. Investigating HDL-C’s utility beyond its conventional role in cholesterol transport is crucial for a comprehensive understanding of COVID-19 and its secondary health effects, such as long-COVID.

Implications of Lipid Remodeling During SARS-CoV-2 Infection

Extensive research indicates that COVID-19 precipitates notable shifts in the host's lipid metabolism, leading to the accumulation of cellular lipid reserves. These alterations aid in the viral takeover of host cellular mechanisms, thus facilitating the progression of the infection. This theory gains support from laboratory evidence showing the cessation of viral replication upon the administration of small molecule lipid inhibitors, highlighting the critical dependence of the virus on host lipid resources for replication.

The Interrelation of Iron Dysregulation, HDL-C, and Ferroptosis in COVID-19

A notable aspect of the interplay between HDL-C functionality and iron homeostasis is the process of ferroptosis, induced by lipid peroxidation and disturbed iron balance, characterized by the buildup of iron and products of lipid oxidation. This leads to diminished antioxidant defense capabilities. HDL-C is influential in mitigating the detrimental effects associated with ferroptosis, underscoring the significance of maintaining balanced iron levels in COVID-19 management.

"Our findings highlight the exacerbating effect of impaired iron regulation on COVID-19 progression, further complicated by the disrupted protective functions of HDL-C", stated Jumana Saleh.

The Dynamic Competition Between Host Metabolic Processes and Viral Interference

The outcome of the "war", between the host's metabolic defenses and viral invasion strategies, axes on the control over iron and lipid resources. The virus strategically targets these metabolic reserves to support its replication and spread. For Marvin Edeas, this battle underscores the complex interaction between host metabolic pathways and viral mechanisms, emphasizing the strategic importance of iron and lipid regulation in determining the course and outcome of COVID-19 infection.

 Marvin Edeas, Founder of the WMS

How does the strategic alteration of iron and HDL-C levels by a virus contribute to its underlying aim of targeting mitochondria to disrupt host defense mechanisms?

Marvin Edeas commented on the perspective of this study.

"In the intricate dance of viral infection, the virus employs a calculated strategy aimed directly at the heart of the host's cellular energy and defense systems — the mitochondria. By subtly manipulating and altering the host's iron metabolism and HDL-C levels, the virus orchestrates a multifaceted attack designed to undermine mitochondrial integrity and function. This strategic disruption serves to weaken the mitochondria, a crucial step in the virus's broader aim to compromise the host's ability to mount an effective defense. Through this sophisticated mechanism of action, the virus ensures its survival and proliferation within the host, highlighting the importance of understanding these viral tactics for the development of targeted therapeutic interventions".

The implications of this study are broad, providing a new understanding of Long COVID-19’s impact on metabolic health and laying the foundation for future research and therapeutic interventions aimed at improving patient outcomes.

Paper DOI.

Photo Credits: Freepik.